Eli Lilly and Co (NEOE:ZLLY) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NEOE:ZLLY Eli Lilly and Co NEOE:ZLLY
75 GF Score
Price C$12.19
GF Value C$15.00
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eli Lilly and Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

NEOE:ZLLY
75GF Score
Eli Lilly and Co NEOE:ZLLY
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (NEOE:ZLLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of C$12.19 is trading 18.7% below its estimated GF Value™ of C$15.00. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for NEOE:ZLLY:

  • Dividends Received:
  • GF Value™: C$15.00 vs. price of C$12.19 (18.7% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the NEOE:ZLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
75GF Score

Get the complete analysis for NEOE:ZLLY

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$12.19
Price
C$15.00
GF Value